Mason bees, subgenus Osmia Panzer (Hymenoptera: Megachilidae), are economically and ecologically significant pollinators. In eastern North America, the rapid spread of 2 non-native species from Asia, Osmia cornifrons Radoszkowski and Osmia taurus Smith, has coincided with declines in native Osmia populations, raising concern about the effects of further exotic arrivals. Here we investigate the recent establishment in British Columbia, Canada of the European orchard bee, Osmia cornuta Latreille, previously thought to be limited to Europe and its periphery. We document O. cornuta records ranging more than 170 km, including sightings of live adults and the discovery of a multigenerational nest with hundreds of cocoons. We tested whether these cocoons could be discriminated from other Osmia species by training a machine learning classifier on features extracted from images. The best performing model could not reliably discriminate cocoons by species, raising the possibility O. cornuta could be inadvertently intermingled in future commercial shipments. Recent occurrence records of O. cornifrons and O. taurus were spatially isolated, suggesting ongoing anthropogenic dispersal of these species. We predicted the suitability of North American habitats for O. cornuta by estimating its native climate niche. This analysis indicated broad regions of the Pacific Northwest and eastern North America contain potentially suitable habitat. Our findings document the establishment of O. cornuta in North America and the potential for its expansion. Our study demonstrates the utility of accessible biodiversity data archives and public observation programs in tracking non-native species spread and highlights the need for future monitoring of exotic Osmia.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11649344PMC
http://dx.doi.org/10.1093/ee/nvae100DOI Listing

Publication Analysis

Top Keywords

north america
16
osmia
8
osmia cornuta
8
hymenoptera megachilidae
8
eastern north
8
non-native species
8
cornuta
6
north
5
species
5
establishment potential
4

Similar Publications

Drug Development.

Alzheimers Dement

December 2024

Genentech, Inc., South San Francisco, CA, USA.

Background: Participant retention is a key determinant for a successful clinical trial. In Alzheimer's disease (AD) trials, participants are typically required to enroll with a study partner, which adds barriers to retention. Previous analyses of North American trial data found that most study partners were spouses and that such dyads had higher study completion rates than other study partner types.

View Article and Find Full Text PDF

Background: Differences in patient characteristics across geographical regions may result in heterogeneity in clinical trial populations. evoke (NCT04777396) and evoke+ (NCT04777409) are two phase 3, multinational, randomised trials investigating semaglutide versus placebo in individuals with mild cognitive impairment or mild dementia due to Alzheimer's disease (AD) (early AD). We present baseline characteristics across the geographical regions in evoke/evoke+.

View Article and Find Full Text PDF

Drug Development.

Alzheimers Dement

December 2024

Signant Health, Blue Bell, PA, USA.

Background: The Mini-Mental State Examination (MMSE) is a common screening tool in Alzheimer's disease (AD) clinical trials. MMSE score inflation at inclusionary visits poses challenges by potentially amplifying placebo responses and complicating the detection of treatment effects. Despite these concerns, prior research (e.

View Article and Find Full Text PDF

Drug Development.

Alzheimers Dement

December 2024

University of Southern California, San Diego, USA.

Background: Recruitment of demographically diverse participants into Alzheimer's disease (AD) clinical trials, encompassing both screening and randomization, remains a consistent and persistent challenge contributing to underrepresentation of certain groups. Despite the exciting prospects of identifying therapeutic interventions for biomarker-eligible, cognitively unimpaired individuals, these studies grapple with the inherent complexities of AD trials coupled with intricate and time-consuming screening processes. Addressing this the issue of underrepresentation necessitates concerted and intentional efforts that prioritize inclusivity and equitable access to enroll adults meeting study criteria, reflecting the demographic and social diversity of North America.

View Article and Find Full Text PDF

Background: Loneliness and depression among older adults are linked to a higher likelihood of chronic diseases, deterioration of physical function, and compromised quality of life. LGBTQ older adults are known to experience social isolation and mental distress at higher rates than their heterosexual counterparts, and those with cognitive impairment may be particularly susceptible to loneliness and depression. However, there is limited knowledge regarding the risk and protective factors for loneliness and depression among LGBTQ older adults living with cognitive impairment.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!